Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 790,990 | 743,300 | 682,584 | 707,059 | 691,138 |
| Cost of Goods | 491,022 | 454,026 | 450,346 | 454,998 | 428,824 |
| Gross Profit | 299,968 | 289,274 | 232,238 | 252,061 | 262,314 |
| Operating Expenses | 171,063 | 156,547 | 155,816 | 158,778 | 154,349 |
| Operating Income | 128,927 | 132,753 | 76,768 | 94,281 | 108,789 |
| Interest Expense | 33,147 | 18,867 | 19,352 | 15,067 | 24,362 |
| Other Income | 76,647 | 21,390 | 26,536 | -23,755 | 21,138 |
| Pre-tax Income | 172,427 | 135,276 | 83,952 | 55,459 | 105,565 |
| Income Tax | 28,237 | 32,665 | 16,284 | 4,622 | 25,053 |
| Net Income Continuous | 144,190 | 102,611 | 67,668 | 50,837 | 80,512 |
| Minority Interests | 999 | -298 | 233 | 68 | 164 |
| Net Income | $143,191 | $102,909 | $67,435 | $50,769 | $80,348 |
| EPS Basic Total Ops | 2.89 | 2.07 | 1.36 | 1.03 | 1.64 |
| EPS Basic Continuous Ops | 2.91 | 2.06 | 1.37 | 1.03 | 1.65 |
| EPS Diluted Total Ops | 2.81 | 2.03 | 1.34 | 1.02 | 1.62 |
| EPS Diluted Continuous Ops | 2.83 | 2.02 | 1.35 | 1.02 | 1.62 |
| EBITDA(a) | $189,803 | $192,333 | $133,976 | $151,541 | $160,622 |